TD Asset Management
FSTX

TD Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

TD Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,687
Closed -$248K – 1521
2022
Q2 		$248K Sell
39,687
-18,800
-32% -$63.3K ﹤0.01% 1370
2022
Q1 		$208K Hold
58,487
– – ﹤0.01% 1425
2021
Q4 		$294K Hold
58,487
– – ﹤0.01% 1425
2021
Q3 		$428K Hold
58,487
– – ﹤0.01% 1415
2021
Q2 		$304K Buy
+58,487
New +$499K ﹤0.01% 1443

Other funds holding FSTX

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Asset Management's FSTX Position: Q3 2022 in Review

TD Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2022, closing a stake of 39,687 shares — an estimated $248K sold.

TD Asset Management first reported a position in FSTX in Q2 2021 and held it in 5 quarters. The position peaked at $428K in Q3 2021. 54 funds tracked by Wall St. Rank hold FSTX as of Q3 2022.

  • TD Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • TD Asset Management sold 39,687 F-star Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $248K.
  • TD Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • TD Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $428K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2022.

Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.